• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Public Health

Conclusions can change following reanalysis of randomized clinical trial data

byPriyanka Vedak
November 30, 2014
in Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. 35% of reanalyzed clinical trials demonstrated conclusions that differed from the conclusions reached by the original article.

2. No statistically significant association was noted between changes in article conclusions following reanalysis and the use of independent versus original study authors.

Evidence Rating Level: 2 (Good)           

Study Rundown: Randomized controlled trials (RCT) are considered the gold standard of medical research. This study aimed to identify those RCTs that underwent reanalysis and to characterize variations in analysis techniques, study authorship, and the effect of this reanalyzed data on trial conclusions. Strengths of this study include the thorough methodology used to identify reanalysis studies. While only 37 reanalyses were ultimately included in this paper, the authors evaluated 2948 studies for appropriateness for inclusion. The results of this study are limited by factors inherent to the journal publication process. As journals may have demonstrated higher interest in the publication of reanalysis studies that disputed original study findings rather than those that confirmed them, the true percentage of clinical trials demonstrating conclusions that differed from the conclusions reached by the original article may in fact be smaller than the percentage identified by this study. Overall, however, this study highlights the paucity of reanalysis studies in the medical literature and reignites the debate surrounding the availability of open access to raw study data.

Click to read the study, published today in JAMA

Click to read the accompanying editorial, published today in JAMA

RELATED REPORTS

Spiritual health may be high among cancer patients in drug clinical trials

Wellness Check: Spirituality

#VisualAbstract: Lecanemab reduced cognitive and functional decline in early Alzheimer’s disease compared to placebo

Relevant Reading: Data: to share or not to share?

In-Depth [systematic review]: This study utilized MEDLINE search terminology to identify 2948 articles reporting reanalysis data. 37 reanalysis were ultimately included and were examined for differences in study characteristics, authorship, statistical analysis methods, and study conclusions. 13 of these studies (35%) demonstrated conclusions different from those reached by the original article. While only 5 reanalyses utilized a panel of authors that was completely different from those individuals involved in the original study, no statistically significant association was noted between changes in article conclusions following reanalysis and the use of independent versus original study authors (Odds Ratio 0.3, Confidence Interval, 0.04-2.11, P=0.32).

More from this author: No mortality benefit with bilateral mastectomy vs breast-conserving surgery, Intermittent vagal nerve block ineffective for weight loss in obesity, Erythropoietin linked with reduced risk of brain injury in preterm infants, Guided patient self-management of blood pressure medications effective, Collaborative model effective in treating teen depression

Image: PD

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.

Tags: Clinical trials
Previous Post

Dementia patients frequently on medications with minimal benefit

Next Post

Paradoxical response to beta-2 agonists found in African-Americans, linked to morbidity

RelatedReports

Survivors of adult-onset cancers associated with increased incidence of cardiovascular disease
Oncology

Spiritual health may be high among cancer patients in drug clinical trials

November 7, 2023
High incidence of cognitive impairment associated with colorectal cancer
Wellness

Wellness Check: Spirituality

November 2, 2023
#VisualAbstract: Lecanemab reduced cognitive and functional decline in early Alzheimer’s disease compared to placebo
StudyGraphics

#VisualAbstract: Lecanemab reduced cognitive and functional decline in early Alzheimer’s disease compared to placebo

May 2, 2023
The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]
COVID-19 Classics

Heparin in noncritically ill COVID-19 patients [Classics Series]

July 17, 2022
Next Post
Dual PDE3/PDE4 inhibitor may be effective treatment for asthma and COPD

Paradoxical response to beta-2 agonists found in African-Americans, linked to morbidity

Shorter moxifloxacin-containing regimens ineffective for treating TB [REMoxTB trial]

Shorter moxifloxacin-containing regimens ineffective for treating TB [REMoxTB trial]

Severe subtype of acute lymphoblastic leukemia susceptible to FDA-approved kinase inhibitors

Severe subtype of acute lymphoblastic leukemia susceptible to FDA-approved kinase inhibitors

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Weighted vests and resistance training confer similar outcomes for bone density in the elderly
  • Breast cancer survivors may have a lower risk of Alzheimer’s dementia
  • Evaluating scar outcomes in pediatric burn patients following skin grafting 
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.